| Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3 A Mangia, R Santoro, N Minerva, GL Ricci, V Carretta, M Persico, F Vinelli, ... New England Journal of Medicine 352 (25), 2609-2617, 2005 | 849 | 2005 |
| Individualized treatment duration for hepatitis C genotype 1 patients: a randomized controlled trial A Mangia, N Minerva, D Bacca, R Cozzolongo, GL Ricci, V Carretta, ... Hepatology 47 (1), 43-50, 2008 | 340 | 2008 |
| Long-term efficacy of interferon alpha-2b and lamivudine in combination compared to lamivudine monotherapy in patients with chronic hepatitis B. An Italian multicenter … G Barbaro, F Zechini, AM Pellicelli, R Francavilla, G Scotto, D Bacca, ... Journal of hepatology 35 (3), 406-411, 2001 | 198 | 2001 |
| Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy T Santantonio, E Medda, C Ferrari, P Fabris, G Cariti, M Massari, ... Clinical infectious diseases 43 (9), 1154-1159, 2006 | 142 | 2006 |
| Interferon alpha-2B and ribavirin in combination for patients with chronic hepatitis C who failed to respond to, or relapsed after, interferon alpha therapy: a randomized trial G Barbaro, G Di Lorenzo, G Belloni, L Ferrari, A Paiano, P Del Poggio, ... The American journal of medicine 107 (2), 112-118, 1999 | 95 | 1999 |
| Determinants of relapse after a short (12 weeks) course of antiviral therapy and re‐treatment efficacy of a prolonged course in patients with chronic hepatitis C virus genotype … A Mangia, N Minerva, D Bacca, R Cozzolongo, E Agostinacchio, F Sogari, ... Hepatology 49 (2), 358-363, 2009 | 79 | 2009 |
| Recommendations for the prevention, diagnosis, and treatment of chronic hepatitis B and C in special population groups (migrants, intravenous drug users and prison inmates) PL Almasio, S Babudieri, G Barbarini, M Brunetto, D Conte, P Dentico, ... Digestive and Liver Disease 43 (8), 589-595, 2011 | 67 | 2011 |
| HBV DNA suppression and HBsAg clearance in HBeAg negative chronic hepatitis B patients on lamivudine therapy for over 5 years M Fasano, P Lampertico, A Marzano, V Di Marco, GA Niro, G Brancaccio, ... Journal of hepatology 56 (6), 1254-1258, 2012 | 61 | 2012 |
| Prevalence of Plasmodium spp. in malaria asymptomatic African migrants assessed by nucleic acid sequence based amplification M Marangi, R Di Tullio, PF Mens, D Martinelli, V Fazio, G Angarano, ... Malaria journal 8, 1-7, 2009 | 59 | 2009 |
| Cryoglobulinemia in subjects with HCV infection alone, HIV infection and HCV/HIV coinfection G Scotto, DC Cibelli, A Saracino, R Prato, E Palumbo, V Fazio, ... Journal of Infection 52 (4), 294-299, 2006 | 49 | 2006 |
| Epidemiological and clinical features of HEV infection: a survey in the district of Foggia (Apulia, Southern Italy) G Scotto, D Martinelli, M Centra, M Querques, F Vittorio, PD Carri, ... Epidemiology & Infection 142 (2), 287-294, 2014 | 46 | 2014 |
| Impact of unreported HIV‐1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non‐nucleoside inhibitors A Saracino, L Monno, L Scudeller, DC Cibelli, A Tartaglia, G Punzi, C Torti, ... Journal of medical virology 78 (1), 9-17, 2006 | 44 | 2006 |
| QuantiFERON®-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy. A Saracino, G Scotto, C Fornabaio, D Martinelli, G Faleo, D Cibelli, ... The new microbiologica 32 (4), 369, 2009 | 43 | 2009 |
| Peg-interferon alpha-2a versus Peg-interferon alpha-2b in nonresponders with HCV active chronic hepatitis: a pilot study G Scotto, V Fazio, C Fornabaio, A Tartaglia, RD Tullio, A Saracino, ... Journal of Interferon & Cytokine Research 28 (10), 623-630, 2008 | 42 | 2008 |
| Association between HLA class II antigens and hepatitis C virus infection. G Scotto, V Fazio, G D'Alessandro, L Monno, A Saracino, E Palumbo, ... Journal of biological regulators and homeostatic agents 17 (4), 316-321, 2003 | 38 | 2003 |
| Pilot study of a short course of ribavirin and alpha interferon in the treatment of chronic active hepatitis C not responding to alpha-interferon alone. G Scotto, V Fazio, G Tantimonaco The Italian journal of gastroenterology 28 (9), 505-511, 1996 | 38 | 1996 |
| Prevalence of HBV-genotypes in immigrants affected by HBV-related chronic active hepatitis E Palumbo, G Scotto, G Faleo, DC Cibelli, A Saracino, G Angarano Arquivos de gastroenterologia 44, 54-57, 2007 | 37 | 2007 |
| Simit epidemiological multicentric study on hospitalized immigrants in Italy during 2002 G Scotto, A Saracino, R Pempinello, IE Hamad, S Geraci, M Panunzio, ... Journal of immigrant Health 7, 55-60, 2005 | 37 | 2005 |
| Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients infected with HCV genotype 3 A Mangia, F Bandiera, G Montalto, L Mottola, V Piazzolla, N Minerva, ... Journal of hepatology 53 (6), 1000-1005, 2010 | 35 | 2010 |
| Epidemiological and clinical features of hepatitis B virus genotypes among immigrants in Southern Italy G Scotto, D Martinelli, R Di Tullio, V Fazio Hepatitis Research and Treatment 2010 (1), 878356, 2010 | 35 | 2010 |
